| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 242.70M | 210.84M | 396.57M | 341.33M | 689.91M | 2.13B |
| Gross Profit | 95.17M | -35.49M | -63.54M | 89.90M | 465.41M | 1.02B |
| EBITDA | -280.87M | -651.93M | -871.38M | -130.08M | -417.54M | 624.10M |
| Net Income | -590.69M | -590.69M | -932.05M | -966.29M | -928.11M | 37.45M |
Balance Sheet | ||||||
| Total Assets | 12.24B | 12.24B | 14.16B | 15.83B | 19.07B | 21.52B |
| Cash, Cash Equivalents and Short-Term Investments | 1.66B | 1.66B | 2.44B | 3.39B | 5.33B | 5.74B |
| Total Debt | 2.91B | 2.91B | 3.87B | 4.26B | 5.46B | 7.15B |
| Total Liabilities | 3.50B | 3.50B | 4.63B | 5.08B | 6.57B | 8.44B |
| Stockholders Equity | 7.61B | 7.61B | 8.24B | 9.27B | 10.72B | 11.31B |
Cash Flow | ||||||
| Free Cash Flow | -154.09M | -306.65M | -371.35M | -130.99M | -83.53M | -165.45M |
| Operating Cash Flow | -264.31M | -305.76M | -371.11M | -126.34M | -81.15M | -150.47M |
| Investing Cash Flow | 290.49M | 376.26M | -51.51M | -60.06M | 3.10B | 931.26M |
| Financing Cash Flow | -979.84M | -984.91M | -422.79M | -1.62B | -1.85B | -101.01M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
52 Neutral | HK$664.38M | -3.08 | -4.79% | 6.05% | 6.17% | 63.88% | |
51 Neutral | HK$701.15M | -5.68 | -2.93% | 3.33% | 178.97% | -2829.91% | |
51 Neutral | HK$667.39M | -1.77 | -4.58% | 3.60% | -4.31% | 19.29% | |
42 Neutral | HK$407.53M | 25.61 | 0.63% | 1.15% | -8.55% | ― | |
39 Underperform | HK$551.94M | -0.93 | -7.61% | ― | -7.97% | 19.98% |
Chuang’s Consortium International Limited reported its unaudited interim results for the six months ending September 30, 2025, highlighting significant financial maneuvers and project developments. The company completed the sale of a subsidiary holding a property in Deep Water Bay, Hong Kong, for HK$538.2 million, enhancing its financial position with net cash proceeds of HK$524.0 million. Additionally, the assignment of debt related to a project in Chengdu, China, was finalized, bringing in HK$103.0 million. The ARUNA project in Ap Lei Chau saw the sale of 42 residential units, generating substantial revenue, with further sales expected in the coming months. Financially, the company holds total cash resources of HK$1.9 billion and reported a reduced loss attributable to equity holders of HK$231.9 million, down from HK$292.8 million the previous year.
The most recent analyst rating on (HK:0367) stock is a Sell with a HK$0.50 price target. To see the full list of analyst forecasts on Chuang’s Consortium International stock, see the HK:0367 Stock Forecast page.
Chuang’s Consortium International Limited has announced a board meeting scheduled for November 27, 2025, in Hong Kong. The meeting will address the company’s interim results for the six months ending September 30, 2025, and consider the payment of dividends, which could impact the company’s financial strategy and shareholder returns.
The most recent analyst rating on (HK:0367) stock is a Sell with a HK$0.50 price target. To see the full list of analyst forecasts on Chuang’s Consortium International stock, see the HK:0367 Stock Forecast page.
Chuang’s Consortium International Limited announced an expected reduction in losses for the six months ending September 30, 2025. The anticipated loss ranges between HK$225 million to HK$265 million, compared to a loss of HK$293 million in the previous period. This improvement is attributed to a decrease in fair value loss of investment properties and impairment provisions for properties under development, despite a net loss from the disposal of a subsidiary holding an investment property.
The most recent analyst rating on (HK:0367) stock is a Sell with a HK$0.50 price target. To see the full list of analyst forecasts on Chuang’s Consortium International stock, see the HK:0367 Stock Forecast page.